Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sociedad Española de Neumología y Cirugía Torácica
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
1. COPD, which after evaluation of its clinical history, belonging to exacerbator phenotype (chronic bronchitic / emphysema) or mixed phenotype ("COPD-asthma") readmission (2 or more income in the previous year) and are stable least six weeks before inclusion in the study.
2. Age over 18 years
3. The patient or caregiver should be able to use the tablet type telematic tool for tracking and monitoring.
You may not be if
1. Patients with severe comorbidity grade IV heart failure, renal failure on hemodialysis or active neoplasia
2. Patients with difficulties phone coverage
3. Patients with lack of adequate social and family support.
4. Patients who do not grant informed consent
Clareo Health | Impact of Telemedicine in the Rate of Readmission for COPD. Project CRONEX 3.0
